A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules
Public ClinicalTrials.gov record NCT04440176. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 2b, RANDOMIZED, OBSERVER-BLINDED TRIAL TO DESCRIBE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MenABCWY ADMINISTERED ON 2 DIFFERENT DOSING SCHEDULES IN HEALTHY PARTICIPANTS ≥11 TO <15 YEARS OF AGE
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to describe the short-term immunogenicity and safety of 2 doses of Neisseria meningitidis group A, B, C, W, and Y vaccine (MenABCWY) separated by either 12 or 36 months during adolescence, and immunopersistence up to 24 months after completing 2 doses separated by a 12-month interval.
Study identification
- NCT ID
- NCT04440176
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 309 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 11 Years to 14 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 16, 2020
- Primary completion
- Jan 4, 2024
- Completion
- Jan 4, 2024
- Last update posted
- Apr 26, 2026
2020 – 2024
United States locations
- U.S. sites
- 20
- U.S. states
- 9
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AMR Clinical | Mobile | Alabama | 36608 | — |
| California Research Foundation | San Diego | California | 92123 | — |
| Nona Pediatric Center | Orlando | Florida | 32829 | — |
| Velocity Clinical Research, Norfolk | Norfolk | Nebraska | 68701 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45206 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | — |
| Ohio Pediatric Research Association Inc. | Dayton | Ohio | 45414 | — |
| Coastal Carolina Research Center | North Charleston | South Carolina | 29405 | — |
| Benchmark Research | Fort Worth | Texas | 76135 | — |
| Texas Health Resources | Fort Worth | Texas | 76135 | — |
| Diagnostics Research Group | San Antonio | Texas | 78229 | — |
| Wee Care Pediatrics | Kaysville | Utah | 84037 | — |
| Wasatch Pediatrics, Cottonwood Office | Murray | Utah | 84107 | — |
| Utah Valley Pediatrics - Timpanogos Office | Orem | Utah | 84057 | — |
| AMR Clinical | Roy | Utah | 84067 | — |
| J. Lewis Research, Inc. / Foothill Family Clinic | Salt Lake City | Utah | 84109 | — |
| J. Lewis Research, Inc. / Foothill Family Clinic South | Salt Lake City | Utah | 84121 | — |
| AMR Clinical | South Jordan | Utah | 84095 | — |
| Wee Care Pediatrics | Syracuse | Utah | 84075 | — |
| Pediatric Research of Charlottesville, LLC | Charlottesville | Virginia | 22902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04440176, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 26, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04440176 live on ClinicalTrials.gov.